These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 31764978

  • 41. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
    Paci M, Passini E, Severi S, Hyttinen J, Rodriguez B.
    Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
    [Abstract] [Full Text] [Related]

  • 42. Cardiotoxicity Assessment of Drugs Using Human iPS Cell-Derived Cardiomyocytes: Toward Proarrhythmic Risk and Cardio-Oncology.
    Satsuka A, Kanda Y.
    Curr Pharm Biotechnol; 2020 Nov; 21(9):765-772. PubMed ID: 31264543
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Proarrhythmia liability assessment and the comprehensive in vitro Proarrhythmia Assay (CiPA): An industry survey on current practice.
    Authier S, Pugsley MK, Koerner JE, Fermini B, Redfern WS, Valentin JP, Vargas HM, Leishman DJ, Correll K, Curtis MJ.
    J Pharmacol Toxicol Methods; 2017 Jul; 86():34-43. PubMed ID: 28223123
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. hiPSC-CM electrophysiology: impact of temporal changes and study parameters on experimental reproducibility.
    Guerrelli D, Pressman J, Salameh S, Posnack N.
    Am J Physiol Heart Circ Physiol; 2024 Jul 01; 327(1):H12-H27. PubMed ID: 38727253
    [Abstract] [Full Text] [Related]

  • 48. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets.
    Shinnawi R, Shaheen N, Huber I, Shiti A, Arbel G, Gepstein A, Ballan N, Setter N, Tijsen AJ, Borggrefe M, Gepstein L.
    J Am Coll Cardiol; 2019 May 14; 73(18):2310-2324. PubMed ID: 31072576
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Utility of Normalized TdP Score System in Drug Proarrhythmic Potential Assessment: A Blinded in vitro Study of CiPA Drugs.
    Liu T, Liu J, Lu HR, Li H, Gallacher DJ, Chaudhary K, Wang Y, Yan GX.
    Clin Pharmacol Ther; 2021 Jun 14; 109(6):1606-1617. PubMed ID: 33283267
    [Abstract] [Full Text] [Related]

  • 51. Modelling Torsade de Pointes arrhythmias in vitro in 3D human iPS cell-engineered heart tissue.
    Kawatou M, Masumoto H, Fukushima H, Morinaga G, Sakata R, Ashihara T, Yamashita JK.
    Nat Commun; 2017 Oct 20; 8(1):1078. PubMed ID: 29057872
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR, Yan GX, Gallacher DJ.
    J Pharmacol Toxicol Methods; 2013 Oct 20; 68(2):250-259. PubMed ID: 23337247
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.